Skip to main content
COVID-19 Response

Learn about the work we're doing and the role it plays in the global fight against coronavirus.

learn more

Recent Press
Mar 4, 2021

Study Will Determine the Safety and Effectiveness of Pulsed Electrical Fields to Interrupt Irregular Heart Rhythms DUBLIN, March 4, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global...

Mar 2, 2021

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac resynchronization therapy (CRT) for...

Feb 23, 2021

- Q3 Revenue of $7.8 Billion Increased 0.8% as Reported and Decreased 1.0% Organically - Q3 GAAP Diluted EPS of $0.94; Q3 Non-GAAP Diluted EPS of $1.29 DUBLIN, Feb. 23, 2021 /PRNewswire/ --...

All Press

Get Notified
You may automatically receive updates from Medtronic by email.
* Required Fields
Advancing ESG Goals
Inclusion & Diversity
Transforming Healthcare
Elevating Women Leaders